Home » Authors » Jennifer Boggs

Jennifer Boggs

Articles

ARTICLES

Radius Adds SARM Program From Karo Bio In $17M Deal

Sep. 13, 2006

By Jennifer Boggs

Radius Adds SARM Program From Karo Bio In $17M Deal

Sep. 13, 2006

By Jennifer Boggs

Metastatix Targeting CXCR4 Receptors In Cancer, HIV

Sep. 12, 2006

By Jennifer Boggs

Metastatix Targeting CXCR4 Receptors In Cancer, HIV

Sep. 12, 2006

By Jennifer Boggs

Medivir Licenses Shingles Drug To Antiviral Start-Up Epiphany

Sep. 11, 2006

By Jennifer Boggs

Medivir Licenses Shingles Drug To Antiviral Start-Up Epiphany

Sep. 11, 2006

By Jennifer Boggs

King Buys Ligand's Avinza Rights For $265M Up Front

Sep. 8, 2006

By Jennifer Boggs

RenaMed Adds $40M Privately For Acute Renal Failure Drug

Sep. 8, 2006

By Jennifer Boggs

RenaMed Adds $40M Privately For Acute Renal Failure Drug

Sep. 8, 2006

By Jennifer Boggs

King Buys Ligand's Avinza Rights For $265M Up Front

Sep. 8, 2006

By Jennifer Boggs

View All Articles by Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...